When is multiagent chemotherapy indicated in the treatment of cutaneous T-cell lymphoma (CTCL)?

Updated: Aug 15, 2018
  • Author: Lauren C Pinter-Brown, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

As previously mentioned, multiagent chemotherapy is used with unequivocal lymph node or systemic involvement or in cases with widespread tumor-stage mycosis fungoides that is refractory to skin-targeted therapies and is not early patch/plaque-stage disease.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!